Nuveen
JBIO

Nuveen’s Jade Biosciences JBIO Stock Holding History

Nuveen’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Buy
76,047
+29,811
+64% +$622K ﹤0.01% 2665
2026
Q1 		$650K Sell
46,236
-78,309
-63% -$1.13M ﹤0.01% 2750
2025
Q4 		$1.92M Buy
124,545
+81,797
+191% +$960K ﹤0.01% 2310
2025
Q3 		$369K Sell
42,748
-17,380
-29% -$142K ﹤0.01% 2995
2025
Q2 		$601K Buy
60,128
+58,984
+5,156% +$2.01M ﹤0.01% 2814
2025
Q1 		$101K Hold
1,144
– – ﹤0.01% 3212
2024
Q4 		$106K Hold
1,144
– – ﹤0.01% 3284
2024
Q3 		$83.7K Hold
1,144
– – ﹤0.01% 3317
2024
Q2 		$66.5K Hold
1,144
– – ﹤0.01% 3317
2024
Q1 		$1.18M Hold
1,144
– – ﹤0.01% 2629
2023
Q4 		$906K Buy
1,144
+107
+10% +$54.5K ﹤0.01% 2779
2023
Q3 		$493K Hold
1,037
– – ﹤0.01% 2850
2023
Q2 		$623K Hold
1,037
– – ﹤0.01% 2859
2023
Q1 		$732K Sell
1,037
-23
-2% -$19.1K ﹤0.01% 2709
2022
Q4 		$1.09M Buy
1,060
+61
+6% +$44.3K ﹤0.01% 2650
2022
Q3 		$580K Sell
999
-109
-10% -$72.8K ﹤0.01% 2929
2022
Q2 		$606K Buy
1,108
+699
+171% +$334K ﹤0.01% 2965
2022
Q1 		$209K Hold
409
– – ﹤0.01% 3185
2021
Q4 		$157K Hold
409
– – ﹤0.01% 3259
2021
Q3 		$300K Buy
+409
New +$229K ﹤0.01% 3253

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen's JBIO Position: Q2 2026 in Review

Nuveen increased its Jade Biosciences (JBIO) stake by 64% in Q2 2026, buying an estimated $622K and bringing the position to 76,047 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

Nuveen first reported a position in JBIO in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.92M in Q4 2025. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Nuveen held 76,047 shares of Jade Biosciences worth $1.69M as of Q2 2026.
  • Nuveen bought 29,811 Jade Biosciences shares in Q2 2026, an estimated $622K.
  • Jade Biosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2665 holding.
  • Nuveen first reported a position in Jade Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Nuveen's Jade Biosciences position peaked at $1.92M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.